Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C | Zendy

James Azim | Zendy; Heather McCurdy | Zendy; Richard H. Moseley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C

Author(s) -

James Azim,

Heather McCurdy,

Richard H. Moseley

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.5913

Subject(s) - porphyria cutanea tarda , ribavirin , medicine , hepatitis c , hemochromatosis , viral hepatitis , porphyria , gastroenterology , immunology , chronic hepatitis , virology , virus

There is a strong association between porphyria cutanea tarda (PCT) and chronic viral hepatitis C. Therapy for chronic viral hepatitis C may improve PCT. However, there are only a few reports of the de novo development of PCT during therapy for chronic viral hepatitis C. We describe the development of PCT in a 56-year-old patient with chronic viral hepatitis C after 12 wk of peginterferon/ribavirin therapy. In addition, the patient was homozygous for the H63D hereditary hemochromatosis gene (HFE) mutation. The association of PCT with chronic viral hepatitis C and the possible role of hepatic iron overload and ribavirin-induced hemolytic anemia in the development of PCT during therapy for chronic viral hepatitis C are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research